Annual General Meeting
|10 Nov||Notice of Annual General Meeting held at 10:40 a.m. on 7 December 2011|
|Attendance Card and Form of Proxy for Annual General Meeting held at 10:40 a.m. on 7 December 2011|
|Notice of General Meeting held at 10:30 a.m. on 7 December 2011|
|Attendance Card and Form of Proxy for General Meeting held at 10:30 a.m. on 7 December 2011|
Shares in issue
As at 21 March 2013 the Company's issued ordinary share capital consisted of 639,360,364 ordinary shares with voting rights. Antisoma does not hold any ordinary shares in Treasury.
The total number of voting rights in Antisoma is 639,360,364.
The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Antisoma under the FSA's Disclosure and Transparency Rules.
As at 21 March 2013 shareholders holding more than 3% of the voting rights of Antisoma were:
|ORA (Guernsey) Limited||29.37|
|BVF Partners LP||7.00|
|Leventis Holding SA||6.94|
|Henderson Global Investors||5.03|
Shares not in public hands
In the terms of AIM Rules published February 2010 and insofar as it is aware, at 21 March 2013, 36.45% of the Company's AIM securities was not in public hands.
Restrictions in transfer of AIM securities
There are no restrictions on the transfer of ordinary shares in the Company.
Antisoma has a Level One American Depositary Receipt (ADR) Program.
This will enable US investors in Antisoma to trade in a dollar-denominated equity instrument.
Trading symbol: ATSMY
CUSIP number: 03718Q109
Ratio: 1 ADR : 20 Ordinary Antisoma shares
Antisoma has appointed The Bank of New York as the depositary bank for our ADR Program.
For more information please contact the Bank of New York:
Page last updated: 21 March 2013